logo-loader
RNS
Prime People

Prime People PLC - Director/PDMR Shareholding

RNS Number : 9497B
Prime People PLC
04 February 2020
 

4 February 2020

Prime People plc

("Prime People" or the "Company") 

Director/PDMR Shareholding

Prime People (AIM: PRP) announces that, on 3 February 2020, the Blakeney Holdings Directors Pension Scheme, a pension scheme in which Sir John Lewis (Non-Executive Director of the Company) holds a beneficial interest, acquired 68,550 ordinary shares of 10 pence each in the capital of the Company ("Ordinary Shares") at a price of 95.05 pence per Ordinary Share from The Crescent Trust, of which Sir John Lewis is deemed to indirectly discharge managerial responsibilities, to effect a transfer between holdings.

 

There is no change to the beneficial interest in Ordinary Shares of Sir John Lewis and persons closely associated as a result of this transaction. Sir John Lewis and persons closely associated beneficially hold a total of 1,094,750 Ordinary Shares, representing approximately 8.9 per cent of the Company's issued share capital.

 

 

For further information, please contact: 

 

 

Prime People  

020 7318 1785

Donka Zaneva-Todorinski, Finance Director

 

Cenkos Securities plc

020 7397 8900

Katy Birkin / Harry Hargreaves

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

The Blakeney Holdings Directors Pension Scheme

2

Reason for the notification

a)

Position/status

Person closely associated with John Lewis, Non-Executive Director

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Prime People Plc

b)

LEI

213800IY9PFL1DOWHY26

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of 10p each

 

Identification code

GB00B4ZG0R74

b)

Nature of the transaction

Purchase of Ordinary Shares to effect a transfer between holdings

c)

Price(s) and volumes(s)

Price(s)

Volume(s)

£0.9505

68,550

d)

Aggregated information

N/A single transaction

 

Aggregated volume

N/A single transaction

 

Price

N/A single transaction

e)

Date of the transaction

3 February 2020

f)

Place of the transaction

AIMX

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

The Crescent Trust

2

Reason for the notification

a)

Position/status

Person closely associated with John Lewis, Non-Executive Director

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Prime People Plc

b)

LEI

213800IY9PFL1DOWHY26

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of 10p each

 

Identification code

GB00B4ZG0R74

b)

Nature of the transaction

Sale of Ordinary Shares to effect a transfer between holdings

c)

Price(s) and volumes(s)

Price(s)

Volume(s)

£0.9500

68,550

d)

Aggregated information

N/A single transaction

 

Aggregated volume

N/A single transaction

 

Price

N/A single transaction

e)

Date of the transaction

3 February 2020

f)

Place of the transaction

AIMX

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHKKQBQQBKDABK
NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...

FOR OUR FULL DISCLAIMER CLICK HERE

3 min read